ATNX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 9.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Athenex Insider Trading History Chart

This chart shows the insider buying and selling history at Athenex by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$10k-$5k$0$5k$10kTotal Insider BuyingTotal Insider Selling

Athenex Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 05/24/2023 05:00 PM ET

This chart shows the closing price history over time for ATNX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Athenex Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Athenex (NASDAQ:ATNX)

30.48% of Athenex stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ATNX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total InflowsTotal Outflows
Athenex logo
Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapies for the treatment of cancer. It operates through the Oncology Innovation Platform and Commercial Platform segments. The Oncology Innovation Platform segment focuses on the research and development of proprietary drugs. The Commercial Platform segment covers the sale and market of specialty drugs and market development of proprietary drugs. The company was founded by Lyn M. Dyster and David G. Hangauer in November 2003 and is headquartered in Buffalo, NY.
Read More on Athenex

Today's Range

Now: N/A

50 Day Range

MA: $0.95
Low: $0.20
High: $1.52

52 Week Range

Now: N/A

Volume

1,880,200 shs

Average Volume

194,316 shs

Market Capitalization

$1.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36